A recent filing from the Hong Kong Stock Exchange reveals that on August 4, Morgan Stanley reduced its holdings in NOVOSENSE (02676) by 73,915 shares. The transaction was executed at an average price of 131.9214 Hong Kong dollars per share, totaling approximately 9.751 million Hong Kong dollars.
Following this reduction, Morgan Stanley's latest shareholding count in the company stands at approximately 1.3583 million shares. This represents a 6.75% stake in the firm, down from its previous position.